Ori Biotech picks up $30m Series A

London-based Ori Biotech Ltd, a cell and gene therapy manufacturer, has raised $30 million in Series A financing.

14 October 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles